CDMRP Breast Cancer Breakthrough Award Level 4

Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome.

Level 4 awards arge-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer. Human clinical trials are required.
 

It is expected that 1 award will be granted. 

Funding : $10,000,000 total

Duration: 4 years

Research Authority due date: 27.7.22

Pre proposal (required) due date: 3.8.22
Full proposal due date: 2.11.22